RxDoctor Payments Data

Sarah Nickells, PA

Physician Assistant · Beaver, PANPI 1558312439

Payments from drug & device makers

$6,294in general payments, 2019–2025

Across 358 payments — averaging $17.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$1K
  • Novo Nordisk$974
  • AbbVie$937
  • Amgen$635
  • Lilly USA, LLC$541
  • Boehringer Ingelheim$349
  • plus $2K from 28 others

What the payments were for

  • Food & beverage$6,285100%
  • Education$90%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$6,294 in reported general payments places this provider in the 95th percentile of 6,643 physician assistant providers in Pennsylvania.

See all physician assistant providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$20,928
Medicare patients
147
Services billed
391

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide60$78,988
EliquisApixaban64$54,972
JardianceEmpagliflozin46$52,302
TrulicityDulaglutide27$36,581
Trelegy ElliptaFluticasone/Umeclidin/Vilanter12$15,334
XareltoRivaroxaban12$14,197
Breo ElliptaFluticasone/Vilanterol22$10,236
Tiagabine Hcl13$9,152
Tegretol XrCarbamazepine13$7,284
Fluticasone-SalmeterolFluticasone Propion/Salmeterol14$2,914
Albuterol Sulfate HfaAlbuterol Sulfate66$2,699
Atorvastatin Calcium240$2,284
Potassium Chloride76$2,028
Omeprazole175$1,944
Captopril14$1,677

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$974$78,98860 claims
PfizerEliquis$293$54,97264 claims
Boehringer IngelheimJardiance$349$52,30246 claims
Lilly USA, LLCTrulicity$541$36,58127 claims
GSKTrelegy Ellipta, Breo Ellipta$1,055$25,57034 claims
Johnson & JohnsonXarelto$30$14,19712 claims
AbbVieSynthroid$937$1,13027 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 6,643 physician assistant providers in Pennsylvania.

Other physician assistant in Beaver

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →